FDA Adverse Event Injury Summary report: N

TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2173391 · Received July 23, 2011

Report

Report Number
2134265-2011-02995
Event Type
Injury
Date Received
July 23, 2011
Date of Event
March 7, 2011
Report Date
June 20, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. PATIENT IDENTIFIER - (B)(6). DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT POST A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION. THE 99% STENOSED TARGET LESION WAS 2.25MM IN DIAMETER AND 8MM LONG LOCATED IN THE RAMUS. THE LESION WAS TREATED WITH DIRECT STENT PLACEMENT OF A 2.25X12MM TAXUS LIBRTE STENT. RESIDUAL STENOSIS WAS 0%. ONE DAY POST INDEX PROCEDURE, THE PATIENT EXPERIENCED ELEVATED CARDIAC ENZYMES CONSISTENT WITH AND ARC MI. NO ACTION WERE TAKEN AND THE EVENT RESOLVED WITHOUT RESIDUAL EFFECTS. THE PATIENT WAS DISCHARGED ON ASPIRIN AND PRASUGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893612220 13824420

Patients

Seq Age Sex Outcome Treatment
1 70 YR Other